Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience
Abstract Background Antimicrobials like fourth-generation cephalosporins, carbapenems, or β-lactams are widely used in treatment of febrile neutropenia (FN). The present study aimed to compare the efficacy of cefepime, meropenem, and piperacillin/tazobactam as initial treatment for chemo-induced FN...
Main Authors: | Najmul Karim, Alamgir Kabir, Manirul Islam, Akhil Ranjan Biswas, Mohammed Wasim, Mahbubul Alam, Nobendu Chowdhury, Mohammed Nadimul Islam, Tamanna Tabassum, Mohammad Jahid Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2022-08-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43162-022-00154-4 |
Similar Items
-
A meta-analysis of piperacillin/tazobactam versus cefepime treatment in cancer patients with febrile neutropenia
by: Zhang Weidong, et al.
Published: (2016-12-01) -
The effect of meropenem versus piperacillin-tazobactam in critically ill patients with sepsis and septic shock
by: Yang Sun, et al.
Published: (2023-06-01) -
Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
by: Bo-Guen Kim, et al.
Published: (2023-05-01) -
Design of an Experimental Study for the Simultaneous Determination of Cefepime, Piperacillin and Tazobactam Using Micellar Organic Solvent-Free HPLC
by: Hani M. Hafez, et al.
Published: (2022-08-01) -
Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem, with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective, Randomized Study
by: Hirozumi Sano, et al.
Published: (2021-10-01)